
The Details...
Reporting to the Director, Applications Bioinformatics, the successful candidate will work with others in the Applications group to interpret sequencing data in a range of biological contexts to answer biological questions and to give best-practice advise to customers and our support teams. Specifically, the candidate will leverage domain expertise for the analysis of data in applications within the biopharma industry. The role will involve evaluating different analysis methods (where appropriate) to understand the differences of the different approaches and to understand the effects that this can have on the final interpretation of the data. The job holder will communicate their findings to internal stakeholders and present the group’s work in meetings and webinars.
Other responsibilities include:
What We're Looking For...
We'll expect you to have a track record of successfully performing appropriate bioinformatics sequence analyses for a range of different kinds of project and a history of involvement in the whole experimental process, from the initial experimental concept to execution. In addition, you'll have practical experience of handling and analyzing large data sets and working closely with lab scientists to continually refine the experimental and analytical approaches.
You're also someone with good communication and interpersonal skills with an enthusiasm for technology. You feel confident discussing and presenting data within the team and with other colleagues. You are versatile, have excellent problem-solving skills and the ability to work on multiple projects simultaneously. In addition, you're experienced with scripting languages, e.g. Python, R, etc. and up to date with the latest literature about NGS and analysis. You'll have an PhD (or equivalent experience) involving a substantial amount of analysis and visualization of DNA and RNA sequence data, ideally with subsequent pos-doctoral or industry experience. Ideally, you will also have specific expertise in analyzing data for biopharmaceutical applications or related applications (e.g. genetic engineering, microbiology, synthetic biology).
This role will suit a creative, self-reliant, positive individual with a can-do attitude and the ability to stay focused in fast-paced situations.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
The salary for this role is between $116,000 and $145,000 USD per annum. The salary offered will reflect the skills and experience of the candidate.
We are proud to be an equal opportunity employer. We select and employ candidates only in accordance with their merits, qualifications, and abilities to perform the duties of the job regardless of gender, marital status, race, religion, color, age, disability, sexual orientation, military or veteran status. If you require an accommodation to complete the application or interview process, please contact human.resources@nanoporetech.com
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.